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The human papillomavirus 16 (HPV-16) E5 oncoprotein is a small integral membrane protein that binds to the 16-kDa
subunit of the vacuolar H1-ATPase (v-ATPase). Conservation within the family of v-ATPases prompted us to look to
Saccharomyces cerevisiae as a potential model organism for E5 study. The E5 open reading frame, driven by a galactose-
inducible promoter, was integrated into the yeast genome, and the resulting strain demonstrated a nearly complete growth
arrest at neutral pH, consistent with defects associated with yeast v-ATPase mutants. Furthermore, this strain demonstrated
a severe reduction in pH-dependent and v-ATPase-dependent vacuolar localization of fluorescent markers. Overexpression
of the yeast 16-kDa subunit homolog partially suppressed E5-associated growth defects. E5 expression was correlated with
a disassociation of the integral (Vo) and peripheral (V i) v-ATPase sub-complexes, as well as a dramatic reduction of the
steady-state levels of one mature Vo subunit and the concomitant accumulation of its major proteolytic fragment, with
unchanged levels of two Vi subunits. Similar analyses of selected E5 mutants in yeast demonstrated a correlation between
E5 biology and v-ATPase disruption. Our observations suggest that wild-type HPV-16 E5 acts during the assembly of the
v-ATPase to inhibit, either directly or indirectly, Vo stability and complex formation. © 2001 Academic Press
Key Words: Papillomavirus; HPV-16 E5 protein; Saccharomyces; vacuolar H1-ATPase.
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iINTRODUCTION
Papillomaviruses are small DNA viruses that produce
proliferative lesions in a number of mammalian hosts.
Human papillomavirus (HPV) infections cause a variety
of benign proliferations including condylomata acumi-
nata (genital warts), epithelial cysts, cervical intraepithe-
lial neoplasias (CIN), papillomas, and other types of
hyperkeratoses. Their involvement in the development of
some major human cancers is a particular health con-
cern. Certain high-risk HPV types (the best-studied ex-
amples being HPV-16 and -18) have been identified as
being causally associated with $90% of cancers of the
cervix as well as with $50% of other anogenital cancers
(zur Hausen, 1996).
All papillomaviruses contain a genome of ;8000 bp,
containing six “early” region open reading frames (ORFs)
and two “late” ORFs. The late ORFs encode the major
and minor structural capsid proteins; the early ORFs
encode proteins involved in viral DNA replication and
viral and cellular transcription. Viral DNA replication, as
well as translation of late viral proteins and viral particle
assembly, is restricted to the differentiating layers of skin
1 Present Address: Department of Pathology, Harvard Medical
chool, Brigham & Women’s Hospital, 75 Francis Street, Boston, MA
2115.t
w
2 To whom reprint requests should be addressed. Fax: (716) 475-
9576. E-mail: djmc@uhura.cc.rochester.edu.
169and mucosa, thus a conventional in vitro system for the
propagation of papillomavirus does not exist. A stratified
squamous epithelial model system has been used to
show that the HPV-16 and -18 genomes can immortalize
and inhibit the differentiation of human keratinocytes
(McCance et al., 1988; Pirisi et al., 1987). Keratinocyte
mmortalization can be accomplished solely by the com-
ined activities of two HPV-16 early gene products, those
f E6 and E7. However, it has been demonstrated that the
5 gene product can act in cis to enhance such immor-
alization #10-fold (Stoppler et al., 1996), perhaps by
nhancing the cellular response to growth factor stimu-
ation (Gu and Matlashewski, 1995). It appears, therefore,
hat these three oncogenes act in concert to maintain the
ost cell in a proliferative state and, in conjunction with
s yet unknown host cell dysfunctions, can lead to the
evelopment of malignant disease.
The HPV-16 E5 protein is a small (83 amino acid),
ighly hydrophobic protein, and as such, localizes to
ntracellular membranes (Bubb et al., 1988). E5 has been
emonstrated to bind to the 16-kDa pore-forming subunit
f the v-ATPase (Adam et al., 2000; Conrad et al., 1993)
nd to inhibit endosomal acidification in human keratin-
cytes (Straight et al., 1995). Previous results from our
aboratory have shown that exogenous E5 expression in
urine fibroblasts leads to a transformed phenotype that
s synergized by EGF (Straight et al., 1993). Furthermore,
he transient expression of E5 in human keratinocytes
as shown to inhibit degradation of internalized EGFR
0042-6822/01 $35.00
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170 BRIGGS, ADAM, AND MCCANCEand enhance the recycling of EGFR to the surface,
thereby amplifying growth factor signaling to the cell.
These observations are consistent with a role for HPV-16
E5 in inhibiting the activity of the v-ATPase through its
binding to the 16-kDa subunit. Moreover, such a role for
HPV-16 E5 would parallel the current understanding of
the bovine papillomavirus type 1 (BPV-1) E5 homolog
(Goldstein and Schlegel, 1990; Martin et al., 1989; Petti et
al., 1991; Schiller et al., 1986).
The eukaryotic vacuole is an organelle central to a
number of essential cellular processes, including: recep-
tor:ligand internalization, turnover, and recycling (Gallo-
way et al., 1988; Johnson et al., 1993; Schandel and
Jenness, 1994); sorting of newly translated proteins from
the endoplasmic reticulum (van Weert et al., 1995); and
mino acid and ion homeostasis (Anraku et al., 1989;
Harrison et al., 1994; Sze et al., 1992). The activity of the
-ATPase in acidifying the vacuolar lumen is necessary
o achieve each of these functions efficiently. Therefore
isruption of the v-ATPase by HPV-16 E5 could have
ramatic effects on the cell in terms of growth, response
o extracellular signals, and production and processing
f newly formed proteins. This contention is exemplified
y the description of a mutant form of the 16-kDa subunit
f the ATPase that at once disrupts binding to E5 and
lso converts the mutant protein into an oncoprotein that
nduces anchorage-independent growth of NIH-3T3 cells
Andresson et al., 1995). This observation highlights the
important role for the ATPase in regulating cell prolifer-
ation and implies that HPV-16 E5 manipulates the v-
ATPase to benefit the propagation of the virus.
The v-ATPase is a structurally and functionally con-
served protein complex, demonstrating remarkable ho-
mology among eukaryotes from fungi to mammals (Kane,
1999; Nelson and Klionsky, 1996). Structurally, all v-ATPases
contain distinct peripheral catalytic portions and hydropho-
bic membrane portions (Kane and Stevens, 1992), which
can assemble together or independently of each other
(Kane, 1992; Kane et al., 1999). The ability to target individual
ene disruptions in the yeast system has allowed for the
reatest advancement in our understanding of the ordered
vents during v-ATPase biosynthesis and assembly and the
onsequences of disrupted v-ATPase activity (Doherty and
ane, 1993; Yamashiro et al., 1990). This level of under-
tanding has been hastened by the development of anti-
odies to various subunits of the ATPase in yeast. There-
ore, the yeast system is ideally suited to dissect the struc-
ural and functional relationship between HPV-16 E5 and
he evolutionarily conserved 16-kDa subunit of the v-AT-
ase. Using Saccharomyces as a register for E5 activity, we
have shown that the expression of this viral protein in yeast
leads to growth and metabolite mobilization defects con-
sistent with alterations in the activity of the v-ATPase. More-
over, E5 expression disrupts the multisubunit v-ATPase,
perhaps during assembly in the endoplasmic reticulum.
s
sRESULTS AND DISCUSSION
Growth and physiology of E5-expressing yeast cells
Mutations in genes encoding various yeast v-ATPase
subunits have been described that lead to a number of
common phenotypes, including an inability of the mutant
cells to grow at neutral pH, while retaining viability in
acidic media (Anraku et al., 1989). We therefore mea-
sured the growth rates of logarithmically growing (;5 3
106 cells/ml) IO and IE5 cells shifted from glucose to
nducing glucose/galactose media buffered to pH 5 or
.5. Recent data from our laboratory (Adam et al., 2000)
evealed that E5 expression led to a defect in growth
nder all conditions examined. Northern analyses dem-
nstrated the moderate accumulation of full-length E5
RNA (indicated in Fig. 1), as well as a prematurely
erminated species. The latter is due to the cleavage and
olyadenylation of cryptic yeast mRNA 39 end formation
ignals in the AT-rich E5 DNA sequence (see Materials
nd Methods). Long exposure of Northerns revealed
light leakiness of the GAL10 promoter (data not shown),
o it was not surprising that E5 caused a growth defect
ven with its promoter in an “uninduced” state. Signifi-
antly, E5-expressing yeast exhibited the most severe
rowth defect compared to wild type in inducing media
uffered to pH 7.5, causing a near complete growth
rrest (Adam et al., 2000). This observation paralleled
hose described for v-ATPase mutants and suggested
hat E5 could be acting through this complex.
The inability to grow at high pH suggested that E5
ells were unable to acidify their vacuoles and maintain
omeostasis with the extracellular environment. We
sed the weakly basic fluorophore quinacrine to exam-
ne the vacuolar acidity of wild-type and E5-expressing
east. When added to the growth media, quinacrine
assively diffuses into acidic subcellular compartments
uch as the vacuole (Weisman et al., 1987) but does not
ccumulate in yeast cells carrying lesions in v-ATPase
FIG. 1. Northern analysis of E5 mRNA induction. Total RNA (10 mg)
repared from indicated strains, either uninduced or partially induced
ith 0.1% glucose/2% galactose, was separated by formaldehyde aga-
ose gel electrophoresis and processed for Northern blotting. Blots
ere probed with an antisense E5 riboprobe and visualized by Phos-
horImaging. Full-length wild-type and mutant E5 mRNAs are indicated
y the arrow.ubunits (Anraku et al., 1989). Since IE5 cells demon-
trated slow growth even under non-inducing conditions,
s171HPV-16 E5 EXPRESSION IN YEASTwe analyzed quinacrine uptake in the two strains in
non-buffered glucose media. As evidenced by Fig. 2A,
while IO cells demonstrated prominent staining of their
vacuoles with quinacrine, IE5 cells were unable to accu-
mulate this marker. These results suggested that E5 is a
potent inhibitor of vacuolar acidification and were con-
sistent with an E5-associated defect in the activity of the
v-ATPase.
The parent yeast strain of the IO and IE5 strains
carries a lesion in the ADE2 gene and produces a pink
pigment in culture and on plates. The pigment is due to
the active (dependent upon the v-ATPase) (Weisman et
FIG. 2. (A) Vacuolar labeling with quinacrine. The weakly basic
fluorophore quinacrine was allowed to passively diffuse into acidic
compartments of wild-type or E5-expressing cells (indicated on the left)
and photographed with phase-contrast (left) or fluorescence (right)
illumination at 340 magnification. (B) Detection of phosphoribosylami-
noamidazole (AIR). IO cells (left) or IE5 cells (right) were analyzed by
overlapping phase-contrast and fluorescence microscopy at 1003
magnification. The origin of the cells photographed (from stationary
liquid culture or from plates) is indicated on the left. These data have
been summarized in Adam et al., 2000.al., 1987) and stable accumulation of a fluorescent inter-
mediate of the adenine biosynthetic pathway (phospho-
p
bribosylaminoimidazole, or “AIR”) in the vacuole. Further-
more, this fluorophore fails to accumulate in strains car-
rying defects in selected v-ATPase subunits (Foury,
1990). We grew strains IO and IE5 in glucose media, and
when both cultures reached stationary phase, we ana-
lyzed them by overlapping phase contrast and fluores-
cent microscopy, to highlight the vacuoles (Fig. 2B, top).
IO cells accumulated the ade2 intermediate to reveal the
prominent vacuole, whereas in IE5 cells, vacuoles were
unlabeled. After an extended period of storage of strain
IE5 on plates at 4°C (ca. 1 month), the normally white
colonies began to turn pink, indicating that E5 expres-
sion does not simply interrupt the adenine biosynthetic
pathway. We examined cells from such plates by micros-
copy (Fig. 2B, bottom) and found that IE5 cells were able
to accumulate the AIR intermediate but not in the vacu-
olar compartment, resulting in diffuse staining through-
out the cell. Since E5 did not inhibit the biosynthesis nor
accumulation of AIR, but merely its transport into the
vacuole, this observation further implied that E5 has a
negative impact on the activity of the v-ATPase.
A particular advantage to using yeast as a model organ-
ism is the well-characterized system developed for genetic
analysis. We attempted to confirm the above-described
phenotypic association of E5 with the v-ATPase by overex-
pressing the VMA3 gene, which encodes the 17-kDa sub-
unit (yeast homolog to the mammalian 16 kDa). VMA3,
controlled by its endogenous promoter, was engineered
onto a high copy plasmid and transformed into the IO and
IE5 strains, and growth was measured with cells grown in
synthetic media for plasmid maintenance. We observed
partial suppression of the E5-associated growth defects
(Adam et al., 2000). In non-inducing or inducing acidic
media, the presence of increased 17-kDa levels did not
affect IE5 cell growth. However, at high pH, when IE5
cells were severely inhibited for growth, overexpression
of the 17 kDa protein restored growth to near wild-type
levels. These observations provided support for our be-
lief that the v-ATPase 17-kDa subunit is being affected by
expression of E5.
E5 alters the ultrastructure of the yeast v-ATPase
To make a more convincing argument for a relation-
ship between E5 expression and the v-ATPase, we ana-
lyzed yeast v-ATPase structure by immunoprecipitation
(IP) of the complex. The ATPase antibodies used were
specific for either a peripheral ATPase subunit of 69 kDa
or an integral ATPase subunit of 100 kDa. Following mild
lysis of yeast spheroplasts in the presence of
crosslinker, the antibodies to the peripheral subunit re-
producibly immunoprecipitated v-ATPase subunits from
the entire complex (Fig. 3, a-69 kDa panel) as demon-
trated previously (Doherty and Kane, 1993). Also as
reviously shown (Kane et al., 1992), the 100-kDa anti-
ody precipitated only the integral membrane portion of
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172 BRIGGS, ADAM, AND MCCANCEthe v-ATPase that was not associated with the peripheral
complex (Fig. 3, a-100 kDa panel). In E5-expressing cells,
e observed that the 69- and 100-kDa antibodies pre-
ipitated reduced levels of indicated v-ATPase subunits,
nd most noticeably when E5 was induced (Fig. 3, lanes
and d). These reductions were consistent with previ-
usly described effects of yeast v-ATPase subunit muta-
ions that interfered with the assembly of the complex
Ho et al., 1993; Kane, 1992).
Interestingly, IPs also revealed a protein band of ;75
Da, again most prominently when E5 was induced. A
rotein band of this size has been shown to accumulate
n various v-ATPase mutants or during prolonged vacu-
lar purification protocols and represents the major pro-
eolytic fragment of the 100-kDa protein, Vph1p (Ho et al.,
993; Kane et al., 1992). We therefore performed Western
nalyses of crude vacuolar extracts to confirm this iden-
ity (Fig. 4). While IO extracts revealed predominantly
ull-length 100-kDa Vph1p, IE5 extracts from cells grown
n inducing media showed a dramatic reduction of full-
ength 100-kDa protein, with almost all of the Vph1p
ccumulating as the 75-kDa proteolytic fragment. Fur-
hermore, analyses using anti-Vi antibodies to the 60-kDa
subunit demonstrated that E5 expression did not dramat-
ically reduce the steady-state levels of this subunit, just
the amount precipitated as a complex (cf. Fig. 3). Taken
together, these E5-associated phenotypes are consistent
FIG. 3. Coimmunoprecipitations of whole-cell extracts from 35S-Cys-
eine-labeled IO and IE5 cells. The extracts used were as follows: (A) IO
lucose, (B) IO glucose/galactose, (C) IE5 glucose, (D) IE5 glucose/
alactose. Either 10% of each labeled whole-cell extract used in im-
unoprecipitations (IPs) or pellets from IPs using mouse IgG, a-v-
ATPase 69-kDa or a-v-ATPase 100-kDa were loaded as indicated.
Products were separated by SDS–PAGE on a 12% gel and the gel was
dried and exposed to a phosphorimager cassette for analysis. Selected
v-ATPase subunits are indicated at the right. The ;75-kDa protein is
indicated by asterisk.with v-ATPase mutants that disrupt the integral portion,
and therefore the assembly, of the v-ATPase complex.
a
pMutant E5 phenotypes correlate with v-ATPase
disruption
In a recent report (Adam et al., 2000), we described the
construction of a number of E5 mutant proteins analyzed
for 16-kDa protein binding in COS-1 cells and growth
defects in yeast. Our work revealed that while all point
mutants bound the pore subunit, certain mutations abro-
gated the ability of E5 to affect yeast growth (cf. Adam et
al., 2000), despite similar levels of expression (cf. Fig. 1).
We therefore analyzed a representative mutant of each
type in our yeast system by IP of metabolically labeled
cells grown in inducing media (Fig. 5). As evidenced in
Fig. 5B, we found that the M5 mutation, which completely
abolished E5-associated growth defects in yeast (Adam
et al., 2000), did not cause reduced ATPase subunit
precipitation with the 100-kDa antibody nor the accumu-
lation of the 75-kDa Vph1p fragment. Conversely, the M2
mutation, which had no effect on E5 activity, appears
identical in IP pattern to wild-type E5. These observa-
tions imply that there is a direct relationship between E5
growth defects and v-ATPase destabilization.
We have demonstrated that in Saccharomyces cerevi-
siae, the expression of HPV-16 E5 leads to a severe
growth defect at neutral pH, an inhibition of the acidifi-
cation of the vacuolar lumen, abrogation of v-ATPase-
dependent compartmentalization of a fluorescent
marker, and destabilization of the v-ATPase complex.
These results are consistent with our model that E5
inhibits v-ATPase function by altering the structure of the
v-ATPase through interactions with the 17-kDa pore-
forming subunit. This effect on v-ATPase structure and/or
assembly by E5 is novel and provides important insights
into the action of the E5 protein. The v-ATPase is one of
FIG. 4. Western blot analyses of v-ATPase subunits from crude
v-ATPase extracts from IO and IE5 grown in inducing media. Unlabeled
v-ATPase extracts (1 mg) from IO- and IE5-induced cells were sepa-
ated by SDS–PAGE on a 10% gel and transferred to nitrocellulose for
equential Western blot analyses using antibodies directed to the 100-
nd 60-kDa v-ATPase subunits. Respective subunits, and the ;75-kDa
roteolytic fragment of Vph1p, are indicated on the left.
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173HPV-16 E5 EXPRESSION IN YEASTa large family of energizing cellular complexes that are
evolutionarily ancient. The 16-kDa pore-forming subunit,
an important target of E5, is 67% identical between mam-
mals and yeast (17-kDa homolog) and 100% identical in
the fourth transmembrane helix shown to be essential for
BPV-1 E5 (Andresson et al., 1995) and HPV-16 E5 binding
Adam et al., 2000). Therefore, our observations may lead
o a greater understanding of the functional significance
f the relationship between E5 and the mammalian v-
TPase 16-kDa subunit.
A comparison of the effects of E5 expression on yeast
rowth to those of deletions of various v-ATPase sub-
nits demonstrates that E5 has associated defects that
re more severe than simple disruption of the complex
Anraku et al., 1989; Kane, 1992). While vma deletion
mutants (deletion of the 17-kDa yeast subunit) show
similarities to E5-expressing cells in their slow growth
and high-pH lethality, E5 expression led to arrest (under
all conditions) so severe that only partial induction of the
protein allowed us to perform the experiments described
in this manuscript. This observation could reflect a dom-
inant-negative relationship between E5 and the 17-kDa
protein, such that the presence of E5 in the cell leads to
an altered function of the pore-forming subunit. Con-
FIG. 5. Coimmunoprecipitations of whole-cell extracts from 35S-Cys-
eine-labeled IO, IE5, and E5 mutant cells grown in inducing media.
rigins of mutant strains used are discussed under Materials and
ethods. (A) 10% of each labeled whole-cell extract used in immuno-
recipitations (IPs) or (B) pellets from IPs using a-v-ATPase 100 kDa.
roducts were separated by SDS–PAGE on a 12% gel, and the gel was
ried and exposed to a phosphorimager cassette for analysis. Selected
-ATPase subunits are indicated. The ;75-kDa Vph1p proteolytic frag-
ent is indicated by asterisk.versely, it could indicate that E5 affects cellular activities
beyond its interaction with the non-essential v-ATPasecomplex and may further underscore the importance of
E5 to the biology and pathology of HPV-16, at least as
evidenced by the yeast system. Further experimentation
with our yeast system will be required to clarify this
issue.
In another report (Adam et al., 2000), our yeast system
has allowed us to determine the potential biological
relevance of E5::v-ATPase binding to vacuolar acidifica-
tion. Those studies indicated that 16-kDa binding is not
sufficient for the biological effect of E5, and our data in
this report complement these findings by implying that a
primary activity of E5 is to disrupt the stability and as-
sembly of the v-ATPase. Taken together, our observa-
tions indicate that E5 does not simply act by blocking the
pore of the v-ATPase but instead leads to the destabili-
zation of the complex.
We have shown that in human keratinocytes E5 ex-
pression inhibits endosomal acidification (Straight et al.,
1995) resulting in reduced epidermal growth factor re-
ceptor degradation and a proliferative response. In
yeast, the fact that disruption of the acidification of the
vacuole, which is central to yeast growth and metabo-
lism, leads to growth inhibition reflects the specialization
of the endosome/lysosome organelle in mammalian
cells. However, we believe that yeast system will allow
the study of E5/v-ATPase interactions and help to deter-
mine functions that can then be tested in the less trac-
table human keratinocyte.
MATERIALS AND METHODS
Strains, plasmids, and culture conditions
Yeast strain SC725 (MATa , leu2-2,112, ade2-101, trp1D1,
his3D200, lys2-801, ura3-52) (a gift of Dr. Eric Phizicky)
was the parent used for the experiments described in
this paper. SC725H was derived from SC725 by integra-
tion of a BamHI fragment from plasmid pJJ215 (Jones and
Prakash, 1990) containing the entire HIS3 locus to repair
the chromosomal lesion. Plasmid YEp51 was a gift from
Dr. Patricia Kane (Broach et al., 1983). The E5 open
reading frame was cloned into this Sal1/Bcl1-cut plasmid
by PCR using oligonucleotides oE5Sal59 (59-ATTTGTC-
GAC ATATGACAAA TCTTGATACT GC-39) and oDE5-329.2
(59-GCTGATCATT ATGTAATCAG AAAGCGTGCA TGTG-
TATGTA TCAAGAACAA TGGTATGTAA ACAAATATGA TG-
39) to produce plasmid YGDE5. The extended length of
oDE5-329.2 was necessary for the incorporation of sin-
gle-base changes within the E5 open reading frame
(indicated in bold). The AT-rich 39 portion of the wild-type
E5 open reading frame signaled premature mRNA 39 end
formation in yeast, so point mutations were generated
that did not alter E5 amino acid sequence, but yielded
detectable full-length E5 mRNA (cf. Fig. 2). YEp51 and
YGDE5 were subjected to PCR using oligonucleotides
oLEU2int (59-GAACGGATCT CCAGATCATC G-39) and
oFLP39 (59-GAGCGCTTCC GAAAATGCAA CGCG-39) and
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174 BRIGGS, ADAM, AND MCCANCEPfu polymerase to generate blunt-ended products. PCR
products were cloned into the HIS3 locus found within
lasmid pJJ217 [a gift of Dr. Eric Phizicky (Jones and
rakash, 1990)], which was cut with NdeI, filled in with
lenow and cut again with Eco47III. Sequence contain-
ng the his3 flanking regions, the selectable LEU2
marker, and the GAL10 promoter and FLP1 terminator
either containing or lacking the E5 ORF was excised by
digestion with PvuII. One microgram of these digests
was used to transform strain SC725H to produce strains
SC725H-his3::YEp51 (“IO”) and SC725H-his3::YGDE5
(“IE5”). Integrations were confirmed by Southern blotting,
and inducible expression of full-length E5 mRNA was
confirmed by Northern blotting. Construction of the E5
M2 (C18G, C20G) and M5 (Y39G) mutations is described
in (Adam et al., 2000).
Complementation of the ade2 defect in working strains
was achieved by transformation with the centromeric
plasmid YCpADE2 (a gift of Dr. Eric Phizicky from E. coli
strain EMP987). Plasmid YEpVMA3 was constructed by
excision of the VMA3 ORF from plasmid pMK9 (Kane et
al., 1992) with EcoRI and PstI and insertion into similarly
cut YEplac195 (Gietz and Sugino, 1988).
Strains were cultured in either standard YPD or Syn-
thetic Complete media lacking indicated amino acids (for
plasmid maintenance) (Sherman et al., 1979). For analy-
ses of growth in inducing and non-inducing media, yeast
cells were grown to stationary phase in rich media (YPD)
and then appropriate numbers of cells were diluted to
early logarithmic phase into buffered rich or synthetic
media containing either 2% dextrose or 0.1% dextrose/2%
galactose [as full induction of E5 led to growth arrest
(Guarente et al., 1982)]. Growth was monitored by optical
density measurements at 600 nm. It is noteworthy that
full induction of E5 expression (in 2% galactose) led to
immediate growth arrest and was therefore abandoned
to allow the phenotypic analyses described below.
Quinacrine labeling has been described (Kane et al.,
1989).
Northern analysis
Total RNA was prepared and Northern analysis carried
out as described previously (Patel, 1992), with blots
probed with an antisense riboprobe specific for E5 de-
rived from plasmid pAT16. Levels of E5 mRNA were
quantitated by storage PhosphorImager analysis (Molec-
ular Dynamics) and normalized to rRNA levels, which
were quantitated by FluorImager analysis (Molecular Dy-
namics) of ethidium bromide-stained gels.
Microscopy
Yeast cells were analyzed by digital microscopy (Olym-
pus BX60 microscope and UV lamp, Optronics Engineer-
ing model DEI-750 digital camera) at either 340 or 3100
magnification under phase-contrast or fluorescence(535-nm excitation, fluorescein filter), as indicated in ap-
propriate figures. Digital images were analyzed using
Adobe Photoshop 5.0 on an Apple Power Macintosh
8100/80AV computer.
Protein analyses
Monoclonal antibodies to three of the v-ATPase sub-
units [gifts of Dr. Patricia Kane (Doherty and Kane, 1993)]
were utilized for immunoprecipitations and Westerns as
described below. Cell labeling and isolation of crude
v-ATPase extracts were isolated as previously described
(Kane et al., 1989). Briefly, 10 ODs of mid-log phase cells
(OD600 5 0.4–0.8) were pelleted, washed with 0.1 M
ris-SO4, pH 9.4, 10 mM DTT, and converted to sphero-
lasts by zymolyase 100T (Sigma) treatment (200 mg
ymolyase in SD-met,cys, 1.2 M sorbitol, 20 min at 30°C).
ells were washed twice with SD-met,cys, 1.2 M sorbitol,
nd 0.5 OD units were resuspended in SD-met,cys, 1.2 M
orbitol at 150 ml per immunoprecipitation, and allowed
to recover at 30°C for 20 min. Cells were labeled with 50
mCi of [35S]cysteine (NEN) for one-half of one cell dou-
bling. Labeled spheroplasts were incubated on ice for 2
min, then pelleted and resuspended in 100 ml solubiliza-
ion buffer per immunoprecipitation (PBS, 1% C12E9
(polyoxyethylene-9 lauryl ether), Sigma] plus protease
inhibitors and 0.75 mM of the crosslinker DSP (dithio-
bis(succinimidyl-propionate) for 1 h on ice. An equal
volume of 50 mM Tris–HCl, pH 7.5, 1 mM EDTA, 10%
glycerol was added to quench the crosslinker for 20 min.
Lysate volumes (200 ml) were raised to 500 ml with
solubilization buffer (lacking C12E9). One microgram of
ouse IgG, 5 ml 8B1 monoclonal antibody (recognizing
the 69-kDa subunit of the v-ATPase), or 250 ml 10D7
monoclonal antibody (recognizing the 100-kDa subunit of
the v-ATPase) was then added. Volumes were raised to 1
ml with PBS plus 20 ml 50% protein A/G Plus–Sepharose
Santa Cruz), and samples were rotated at 4°C overnight.
mmune complexes were washed two times with 10 mM
ris–HCl pH 8.0, 1% Triton X-100, 20 mM EDTA. Samples
ere separated on 12% SDS polyacrylamide gels, and
he gels were dried and exposed to a phosphorimager
creen for analysis. For Western analyses, 1 mg of unla-
eled crude v-ATPase extracts from IO and IE5 strains
ere separated by SDS–PAGE on a 10% gel and trans-
erred to nitrocellulose. After blocking in PBS/0.1%
ween-20/5% milk, primary antibodies 8B1 (69 kDa),
3D11 (60 kDa), and 10D7 (100 kDa) were added at
1:1000, 1:2000, and 1:500, respectively) for 1 h. After four
BST washes, secondary antibodies (goat anti mouse-
RP, 1:2000, Santa Cruz) were added for 1 h. The blot
as washed as before, ECL reagent was added (NEN),
nd the blot was exposed to film for visualization.
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